NCT06735235View on ClinicalTrials.gov

Salivary Fluoride Clearance

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 14, 2021

Primary Completion Date

July 29, 2021

Study Completion Date

July 29, 2021

Conditions
Caries
Interventions
DRUG

0 ppm F

Each subject will be randomly assigned to this treatment during one of the four periods for this crossover study.

DRUG

250 ppm F as MFP

Each subject will be randomly assigned to this treatment during one of the four periods for this crossover study.

DRUG

1100 ppm as MFP

Each subject will be randomly assigned to this treatment during one of the four periods for this crossover study.

DRUG

2800 ppm F as MFP

Each subject will be randomly assigned to this treatment during one of the four periods for this crossover study.

Trial Locations (1)

45040

Oral Health Science Center, Mason

All Listed Sponsors
lead

Procter and Gamble

INDUSTRY